These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 39421656)
21. Tissue-specific role of Nrf2 in the treatment of diabetic foot ulcers during hyperbaric oxygen therapy. Dhamodharan U; Karan A; Sireesh D; Vaishnavi A; Somasundar A; Rajesh K; Ramkumar KM Free Radic Biol Med; 2019 Jul; 138():53-62. PubMed ID: 31035003 [TBL] [Abstract][Full Text] [Related]
22. Swift Downregulation of Gelatinases (MMP-2, MMP-9) in Neuropathic Diabetic Foot Ulcers Treated With Total Contact Cast. Alvarez OM; Markowitz L; Onumah N; Wendelken M Wounds; 2019 May; 31(5):E39-E41. PubMed ID: 31184591 [TBL] [Abstract][Full Text] [Related]
23. A Meta-Analysis of the Outcomes of Metatarsal Head Resection for the Treatment of Neuropathic Diabetic Foot Ulcers. Yammine K; Kheir N; Assi C Adv Wound Care (New Rochelle); 2021 Feb; 10(2):81-90. PubMed ID: 32870773 [No Abstract] [Full Text] [Related]
24. Clinical comprehensive treatment protocol for managing diabetic foot ulcers: A retrospective cohort study. Wang YB; Lv Y; Li GY; Zheng JT; Jiang QX; Wei R World J Clin Cases; 2024 Jun; 12(17):2976-2982. PubMed ID: 38898850 [TBL] [Abstract][Full Text] [Related]
25. Comparative Study of Different Treatment Options of Grade III and IV Diabetic Foot Ulcers to Reduce the Incidence of Amputations. Khandelwal S; Chaudhary P; Poddar DD; Saxena N; Singh RA; Biswal UC Clin Pract; 2013 Jan; 3(1):e9. PubMed ID: 24765502 [TBL] [Abstract][Full Text] [Related]
26. The importance of growth factors for the treatment of chronic wounds in the case of diabetic foot ulcers. Buchberger B; Follmann M; Freyer D; Huppertz H; Ehm A; Wasem J GMS Health Technol Assess; 2010 Sep; 6():Doc12. PubMed ID: 21289885 [TBL] [Abstract][Full Text] [Related]
27. A clinical practice guideline for the use of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers. Huang ET; Mansouri J; Murad MH; Joseph WS; Strauss MB; Tettelbach W; Worth ER; Undersea Hyperb Med; 2015; 42(3):205-47. PubMed ID: 26152105 [TBL] [Abstract][Full Text] [Related]
28. Treatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysis. Kantor J; Margolis DJ Dermatol Surg; 2001 Apr; 27(4):347-51. PubMed ID: 11298704 [TBL] [Abstract][Full Text] [Related]
29. Hyperbaric oxygen therapy for non-healing ulcers in diabetes mellitus: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2005; 5(11):1-28. PubMed ID: 23074462 [TBL] [Abstract][Full Text] [Related]
30. Increased ratio of serum matrix metalloproteinase-9 against TIMP-1 predicts poor wound healing in diabetic foot ulcers. Li Z; Guo S; Yao F; Zhang Y; Li T J Diabetes Complications; 2013; 27(4):380-2. PubMed ID: 23357650 [TBL] [Abstract][Full Text] [Related]
32. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. O'Meara S; Cullum N; Majid M; Sheldon T Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391 [TBL] [Abstract][Full Text] [Related]
33. Hyperbaric oxygen (HBO) therapy in treatment of diabetic foot ulcers. Long-term follow-up. Kalani M; Jörneskog G; Naderi N; Lind F; Brismar K J Diabetes Complications; 2002; 16(2):153-8. PubMed ID: 12039398 [TBL] [Abstract][Full Text] [Related]
34. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers. Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261 [TBL] [Abstract][Full Text] [Related]
35. [Prevention of diabetic foot]. Metelko Z; Brkljacić Crkvencić N Acta Med Croatica; 2013 Oct; 67 Suppl 1():35-44. PubMed ID: 24371974 [TBL] [Abstract][Full Text] [Related]
36. Matrix Metalloproteinase-9 Testing of Golden Rice Cookies With Piper Crocatum Active Extract for Preventing Foot Ulcers in Patients With Diabetes: Protocol for a Randomized Controlled Trial. Setyawati A; Saleh A; Tahir T; Yusuf S; Syahrul S; Aminuddin A; Raihan M; Jafar N; Hamzah H; Arfian N JMIR Res Protoc; 2024 Feb; 13():e49940. PubMed ID: 38422498 [TBL] [Abstract][Full Text] [Related]
37. Translational development of ABCB5 Kerstan A; Dieter K; Niebergall-Roth E; Klingele S; Jünger M; Hasslacher C; Daeschlein G; Stemler L; Meyer-Pannwitt U; Schubert K; Klausmann G; Raab T; Goebeler M; Kraft K; Esterlechner J; Schröder HM; Sadeghi S; Ballikaya S; Gasser M; Waaga-Gasser AM; Murphy GF; Orgill DP; Frank NY; Ganss C; Scharffetter-Kochanek K; Frank MH; Kluth MA Stem Cell Res Ther; 2022 Sep; 13(1):455. PubMed ID: 36064604 [TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of tRNA-derived small RNAs reveals new therapeutic genes of hyperbaric oxygen in diabetic foot ulcers. Yan Z; Cui X; Huang M; Luo Z; Zhou Q; Li H; Duan M; Yan Z; Ran Y; Zhang P; Jiang B; Liang P; Huang X Epigenomics; 2021 Nov; 13(22):1817-1829. PubMed ID: 34657473 [No Abstract] [Full Text] [Related]
39. [Protein expressions of matrix metalloproteinase-9 and its inhibitor and their ratio changes in wound healing of patients with stages Ⅲ and Ⅳ pressure ulcers]. Wang Y; Li X; Zhao W; Gao ZZ; Zheng MJ; Pang YL; Chen ZY Zhonghua Shao Shang Za Zhi; 2019 Oct; 35(10):746-751. PubMed ID: 31658546 [No Abstract] [Full Text] [Related]
40. A prospective, randomized, controlled study of hyperbaric oxygen therapy: effects on healing and oxidative stress of ulcer tissue in patients with a diabetic foot ulcer. Ma L; Li P; Shi Z; Hou T; Chen X; Du J Ostomy Wound Manage; 2013 Mar; 59(3):18-24. PubMed ID: 23475448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]